RNA-mediated pathogenesis in fragile X-associated disorders

Neuroscience Letters

Volumn 466, Issue 2, 2009, Pages 103-108

  Tan, Huiping ^a,b   Li, He ^b   Jin, Peng ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

FMR1; Fragile X syndrome; FXTAS; Noncoding RNAs

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MICRORNA; UNTRANSLATED RNA;

FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE REPEAT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN RNA BINDING; REGULATORY MECHANISM; REVIEW; RNA PROCESSING; RNA TRANSLATION;

FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; RNA, UNTRANSLATED;

EID: 70350117848     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.053     Document Type: Review

References (66)

1. Arocena D.G., Iwahashi C.K., Won N., Beilina A., Ludwig A.L., Tassone F., Schwartz P.H., and Hagerman P.J. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum. Mol. Genet. 14 (2005) 3661-3671
2. Ashley Jr. C.T., Wilkinson K.D., Reines D., and Warren S.T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262 (1993) 563-566
3. Bacalman S., Farzin F., Bourgeois J.A., Cogswell J., Goodlin-Jones B.L., Gane L.W., Grigsby J., Leehey M.A., Tassone F., and Hagerman R.J. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J. Clin. Psychiatry 67 (2006) 87-94
4. Barbee S.A., Estes P.S., Cziko A.M., Hillebrand J., Luedeman R.A., Coller J.M., Johnson N., Howlett I.C., Geng C., Ueda R., Brand A.H., Newbury S.F., Wilhelm J.E., Levine R.B., Nakamura A., Parker R., and Ramaswami M. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 52 (2006) 997-1009
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
6. Bassell G.J., and Warren S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60 (2008) 201-214
7. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., Weng Z., Snyder M., Dermitzakis E.T., Thurman R.E., Kuehn M.S., Taylor C.M., Neph S., Koch C.M., Asthana S., Malhotra A., Adzhubei I., Greenbaum J.A., Andrews R.M., Flicek P., Boyle P.J., Cao H., Carter N.P., Clelland G.K., Davis S., Day N., Dhami P., Dillon S.C., Dorschner M.O., Fiegler H., Giresi P.G., Goldy J., Hawrylycz M., Haydock A., Humbert R., James K.D., Johnson B.E., Johnson E.M., Frum T.T., Rosenzweig E.R., Karnani N., Lee K., Lefebvre G.C., Navas P.A., Neri F., Parker S.C., Sabo P.J., Sandstrom R., Shafer A., Vetrie D., Weaver M., Wilcox S., Yu M., Collins F.S., Dekker J., Lieb J.D., Tullius T.D., Crawford G.E., Sunyaev S., Noble W.S., Dunham I., Denoeud F., Reymond A., Kapranov P., Rozowsky J., Zheng D., Castelo R., Frankish A., Harrow J., Ghosh S., Sandelin A., Hofacker I.L., Baertsch R., Keefe D., Dike S., Cheng J., Hirsch H.A., Sekinger E.A., Lagarde J., Abril J.F., Shahab A., Flamm C., Fried C., Hackermuller J., Hertel J., Lindemeyer M., Missal K., Tanzer A., Washietl S., Korbel J., Emanuelsson O., Pedersen J.S., Holroyd N., Taylor R., Swarbreck D., Matthews N., Dickson M.C., Thomas D.J., Weirauch M.T., Gilbert J., Drenkow J., Bell I., Zhao X., Srinivasan K.G., Sung W.K., Ooi H.S., Chiu K.P., Foissac S., Alioto T., Brent M., Pachter L., Tress M.L., Valencia A., Choo S.W., Choo C.Y., Ucla C., Manzano C., Wyss C., Cheung E., Clark T.G., Brown J.B., Ganesh M., Patel S., Tammana H., Chrast J., Henrichsen C.N., Kai C., Kawai J., Nagalakshmi U., Wu J., Lian Z., Lian J., Newburger P., Zhang X., Bickel P., Mattick J.S., Carninci P., Hayashizaki Y., Weissman S., Hubbard T., Myers R.M., Rogers J., Stadler P.F., Lowe T.M., Wei C.L., Ruan Y., Struhl K., Gerstein M., Antonarakis S.E., Fu Y., Green E.D., Karaoz U., Siepel A., Taylor J., Liefer L.A., Wetterstrand K.A., Good P.J., Feingold E.A., Guyer M.S., Cooper G.M., Asimenos G., Dewey C.N., Hou M., Nikolaev S., Montoya-Burgos J.I., Loytynoja A., Whelan S., Pardi F., Massingham T., Huang H., Zhang N.R., Holmes I., Mullikin J.C., Ureta-Vidal A., Paten B., Seringhaus M., Church D., Rosenbloom K., Kent W.J., Stone E.A., Batzoglou S., Goldman N., Hardison R.C., Haussler D., Miller W., Sidow A., Trinklein N.D., Zhang Z.D., Barrera L., Stuart R., King D.C., Ameur A., Enroth S., Bieda M.C., Kim J., Bhinge A.A., Jiang N., Liu J., Yao F., Vega V.B., Lee C.W., Ng P., Shahab A., Yang A., Moqtaderi Z., Zhu Z., Xu X., Squazzo S., Oberley M.J., Inman D., Singer M.A., Richmond T.A., Munn K.J., Rada-Iglesias A., Wallerman O., Komorowski J., Fowler J.C., Couttet P., Bruce A.W., Dovey O.M., Ellis P.D., Langford C.F., Nix D.A., Euskirchen G., Hartman S., Urban A.E., Kraus P., Van Calcar S., Heintzman N., Kim T.H., Wang K., Qu C., Hon G., Luna R., Glass C.K., Rosenfeld M.G., Aldred S.F., Cooper S.J., Halees A., Lin J.M., Shulha H.P., Zhang X., Xu M., Haidar J.N., Yu Y., Ruan Y., Iyer V.R., Green R.D., Wadelius C., Farnham P.J., Ren B., Harte R.A., Hinrichs A.S., Trumbower H., Clawson H., Hillman-Jackson J., Zweig A.S., Smith K., Thakkapallayil A., Barber G., Kuhn R.M., Karolchik D., Armengol L., Bird C.P., de Bakker P.I., Kern A.D., Lopez-Bigas N., Martin J.D., Stranger B.E., Woodroffe A., Davydov E., Dimas A., Eyras E., Hallgrimsdottir I.B., Huppert J., Zody M.C., Abecasis G.R., Estivill X., Bouffard G.G., Guan X., Hansen N.F., Idol J.R., Maduro V.V., Maskeri B., McDowell J.C., Park M., Thomas P.J., Young A.C., Blakesley R.W., Muzny D.M., Sodergren E., Wheeler D.A., Worley K.C., Jiang H., Weinstock G.M., Gibbs R.A., Graves T., Fulton R., Mardis E.R., Wilson R.K., Clamp M., Cuff J., Gnerre S., Jaffe D.B., Chang J.L., Lindblad-Toh K., Lander E.S., Koriabine M., Nefedov M., Osoegawa K., Yoshinaga Y., Zhu B., and de Jong P.J. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 (2007) 799-816
8. Caudy A.A., Myers M., Hannon G.J., and Hammond S.M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 16 (2002) 2491-2496
9. Cheever A., and Ceman S. Phosphorylation of FMRP inhibits association with Dicer. RNA 15 (2009) 362-366
10. Cheever A., and Ceman S. Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway. RNA Biol. 6 (2009)
11. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., and Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5401-5404
12. Darnell J.C., Fraser C.E., Mostovetsky O., Stefani G., Jones T.A., Eddy S.R., and Darnell R.B. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev. 19 (2005) 903-918
13. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., and Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107 (2001) 489-499
14. De Boulle K., Verkerk A.J., Reyniers E., Vits L., Hendrickx J., Van Roy B., Van den Bos F., de Graaff E., Oostra B.A., and Willems P.J. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3 (1993) 31-35
15. Dombrowski C., Levesque S., Morel M.L., Rouillard P., Morgan K., and Rousseau F. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum. Mol. Genet. 11 (2002) 371-378
16. Feng Y., Absher D., Eberhart D.E., Brown V., Malter H.E., and Warren S.T. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1 (1997) 109-118
17. Feng Y., Gutekunst C.A., Eberhart D.E., Yi H., Warren S.T., and Hersch S.M. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17 (1997) 1539-1547
18. Feng Y., Zhang F., Lokey L.K., Chastain J.L., Lakkis L., Eberhart D., and Warren S.T. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268 (1995) 731-734
19. Fu Y.H., Kuhl D.P., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., Verkerk A.J., Holden J.J., Fenwick Jr. R.G., Warren S.T., Oostra B.A., Nelson D.L., and Caskey C.T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67 (1991) 1047-1058
20. Greco C.M., Berman R.F., Martin R.M., Tassone F., Schwartz P.H., Chang A., Trapp B.D., Iwahashi C., Brunberg J., Grigsby J., Hessl D., Becker E.J., Papazian J., Leehey M.A., Hagerman R.J., and Hagerman P.J. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129 (2006) 243-255
21. Greco C.M., Hagerman R.J., Tassone F., Chudley A.E., Del Bigio M.R., Jacquemont S., Leehey M., and Hagerman P.J. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125 (2002) 1760-1771
22. Grigsby J., Brega A.G., Jacquemont S., Loesch D.Z., Leehey M.A., Goodrich G.K., Hagerman R.J., Epstein J., Wilson R., Cogswell J.B., Jardini T., Tassone F., and Hagerman P.J. Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J. Neurol. Sci. (2006)
23. Hagerman P.J., and Hagerman R.J. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004) 25-30
24. Hagerman P.J., and Hagerman R.J. The fragile-X premutation: a maturing perspective. Am. J. Hum. Genet. 74 (2004) 805-816
25. Hagerman R.J., Leavitt B.R., Farzin F., Jacquemont S., Greco C.M., Brunberg J.A., Tassone F., Hessl D., Harris S.W., Zhang L., Jardini T., Gane L.W., Ferranti J., Ruiz L., Leehey M.A., Grigsby J., and Hagerman P.J. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am. J. Hum. Genet. 74 (2004) 1051-1056
26. Hashem V., Galloway J.N., Mori M., Willemsen R., Oostra B.A., Paylor R., and Nelson D.L. Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum. Mol. Genet. (2009)
27. Hessl D., Tassone F., Loesch D.Z., Berry-Kravis E., Leehey M.A., Gane L.W., Barbato I., Rice C., Gould E., Hall D.A., Grigsby J., Wegelin J.A., Harris S., Lewin F., Weinberg D., Hagerman P.J., and Hagerman R.J. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 139 (2005) 115-121
28. Ishizuka A., Siomi M.C., and Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 16 (2002) 2497-2508
29. Jacquemont S., Hagerman R.J., Leehey M.A., Hall D.A., Levine R.A., Brunberg J.A., Zhang L., Jardini T., Gane L.W., Harris S.W., Herman K., Grigsby J., Greco C.M., Berry-Kravis E., Tassone F., and Hagerman P.J. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291 (2004) 460-469
30. Jacquemont S., Leehey M.A., Hagerman R.J., Beckett L.A., and Hagerman P.J. Size bias of fragile X premutation alleles in late-onset movement disorders. J. Med. Genet. (2006)
31. Jin P., Alisch R.S., and Warren S.T. RNA and microRNAs in fragile X mental retardation. Nat. Cell. Biol. 6 (2004) 1048-1053
32. Jin P., Duan R., Qurashi A., Qin Y., Tian D., Rosser T.C., Liu H., Feng Y., and Warren S.T. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55 (2007) 556-564
33. Jin P., Zarnescu D.C., Ceman S., Nakamoto M., Mowrey J., Jongens T.A., Nelson D.L., Moses K., and Warren S.T. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat. Neurosci. 7 (2004) 113-117
34. Jin P., Zarnescu D.C., Zhang F., Pearson C.E., Lucchesi J.C., Moses K., and Warren S.T. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39 (2003) 739-747
35. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., Stadler P.F., Hertel J., Hackermuller J., Hofacker I.L., Bell I., Cheung E., Drenkow J., Dumais E., Patel S., Helt G., Ganesh M., Ghosh S., Piccolboni A., Sementchenko V., Tammana H., and Gingeras T.R. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316 (2007) 1484-1488
36. Kenneson A., Zhang F., Hagedorn C.H., and Warren S.T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 10 (2001) 1449-1454
37. Khalili K., Del Valle L., Muralidharan V., Gault W.J., Darbinian N., Otte J., Meier E., Johnson E.M., Daniel D.C., Kinoshita Y., Amini S., and Gordon J. Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol. Cell. Biol. 23 (2003) 6857-6875
38. Khalil A.M., Faghihi M.A., Modarresi F., Brothers S.P., and Wahlestedt C. A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One 3 (2008) e1486
39. Kremer E.J., Pritchard M., Lynch M., Yu S., Holman K., Baker E., Warren S.T., Schlessinger D., Sutherland G.R., and Richards R.I. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252 (1991) 1711-1714
40. Ladd P.D., Smith L.E., Rabaia N.A., Moore J.M., Georges S.A., Hansen R.S., Hagerman R.J., Tassone F., Tapscott S.J., and Filippova G.N. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 16 (2007) 3174-3187
41. Laggerbauer B., Ostareck D., Keidel E.M., Ostareck-Lederer A., and Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10 (2001) 329-338
42. Leehey M.A., Berry-Kravis E., Goetz C.G., Zhang L., Hall D.A., Li L., Rice C.D., Lara R., Cogswell J., Reynolds A., Gane L., Jacquemont S., Tassone F., Grigsby J., Hagerman R.J., and Hagerman P.J. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology 70 (2008) 1397-1402
43. Li Z., Zhang Y., Ku L., Wilkinson K.D., Warren S.T., and Feng Y. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29 (2001) 2276-2283
44. Lugenbeel K.A., Peier A.M., Carson N.L., Chudley A.E., and Nelson D.L. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome. Nat. Genet. 10 (1995) 483-485
45. Lugli G., Larson J., Martone M.E., Jones Y., and Smalheiser N.R. Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J. Neurochem. 94 (2005) 896-905
46. Nimchinsky E.A., Oberlander A.M., and Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21 (2001) 5139-5146
47. Oberle I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., Boue J., Bertheas M.F., and Mandel J.L. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (1991) 1097-1102
48. Pieretti M., Zhang F.P., Fu Y.H., Warren S.T., Oostra B.A., Caskey C.T., and Nelson D.L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66 (1991) 817-822
49. Ranum L.P., and Cooper T.A. RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 29 (2006) 259-277
50. Schaeffer C., Bardoni B., Mandel J.L., Ehresmann B., Ehresmann C., and Moine H. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20 (2001) 4803-4813
51. Siomi M.C., Siomi H., Sauer W.H., Srinivasan S., Nussbaum R.L., and Dreyfuss G. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14 (1995) 2401-2408
52. Sofola O.A., Jin P., Qin Y., Duan R., Liu H., de Haro M., Nelson D.L., and Botas J. RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55 (2007) 565-571
53. Stefani G., Fraser C.E., Darnell J.C., and Darnell R.B. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J. Neurosci. 24 (2004) 9272-9276
54. Tassone F., Hagerman R.J., Garcia-Arocena D., Khandjian E.W., Greco C.M., and Hagerman P.J. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J. Med. Genet. 41 (2004) e43
55. Tassone F., Hagerman R.J., Taylor A.K., Gane L.W., Godfrey T.E., and Hagerman P.J. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66 (2000) 6-15
56. Tassone F., Iwahashi C., and Hagerman P.J. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol. 1 (2004) 103-105
57. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F.P., Eussen B.E., Van Ommen G.B., Blonden L.A., Riggins G.J., Chastain J.L., Kunst C.B., Galjaard H., Caskey C.T., Nelson D.L., Oostra B.A., and Warren S.T. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 (1991) 905-914
58. Warren S.T., and Sherman S.L. The fragile X syndrome. In: Scriver C.R., Beaudet A.L., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Bases of Inherited Disease vol. I (2001), McGraw-Hill Companies, New York 1257-1290
59. Willemsen R., Hoogeveen-Westerveld M., Reis S., Holstege J., Severijnen L.A., Nieuwenhuizen I.M., Schrier M., van Unen L., Tassone F., Hoogeveen A.T., Hagerman P.J., Mientjes E.J., and Oostra B.A. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum. Mol. Genet. 12 (2003) 949-959
60. Wohrle D., Kotzot D., Hirst M.C., Manca A., Korn B., Schmidt A., Barbi G., Rott H.D., Poustka A., Davies K.E., and Steinbach P. A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am. J. Hum. Genet. 51 (1992) 299-306
61. Xu K., Bogert B.A., Li W., Su K., Lee A., and Gao F.B. The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1. Curr. Biol. 14 (2004) 1025-1034
62. Xu X.L., Li Y., Wang F., and Gao F.B. The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila. J. Neurosci. 28 (2008) 11883-11889
63. Yang L., Duan R., Chen D., Wang J., and Jin P. Fragile X mental retardation protein modulates the fate of germline stem cells in Drosophila. Hum. Mol. Genet. 16 (2007) 1814-1820
64. Yang Y., Xu S., Xia L., Wang J., Jin P., and Chen D. MicroRNA Bantam is associated with Drosophila Fragile X mental retardation protein and regulates the fate of germline stem cells. PLoS Genetics 5 (2009) e1000444
65. Zhang Y., O'Connor J.P., Siomi M.C., Srinivasan S., Dutra A., Nussbaum R.L., and Dreyfuss G. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO. J. 14 (1995) 5358-5366
66. Zuhlke C., Budnik A., Gehlken U., Dalski A., Purmann S., Naumann M., Schmidt M., Burk K., and Schwinger E. FMR1 premutation as a rare cause of late onset ataxia-evidence for FXTAS in female carriers. J. Neurol. 251 (2004) 1418-1419